Scleroderma echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Overview

There are no echocardiography/ultrasound findings directly associated with scleroderma diagnosis. However, a transthoracic echocardiography (TTE) may be helpful in the diagnosis of complications of scleroderma, which include pulmonary arterial hypertension (PAH).

Echocardiography/Ultrasound

There are no echocardiography/ultrasound findings associated with scleroderma. However, a transthoracic echocardiography (TTE) may be helpful in the diagnosis of complications of scleroderma, which include:^[1]^[2]

Pulmonary arterial hypertension (PAH)
- For the findings associated with pulmonary arterial hypertension (PAH) on transthoracic echocardiography click here.

References

↑ McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J (April 2009). “ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association”. J. Am. Coll. Cardiol. 53 (17): 1573–619. doi:10.1016/j.jacc.2009.01.004. PMID 19389575.
↑ Morrisroe K, Stevens W, Sahhar J, Rabusa C, Nikpour M, Proudman S (March 2017). “Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme”. Arthritis Res. Ther. 19 (1): 42. doi:10.1186/s13075-017-1250-z. PMC 5341425. PMID 28270192.

Overview